- Show all
- Abigail Coursolle
- Alejandra Pavisich
- Alejandra Pavisich
- Alexis Robles-Fradet
- Alicia Emanuel
- Amanda Avery
- Amy Chen
- Andy DiAntonio
- Arielle Linsey
- Brian Brooks
- Candace Gibson
- Carly Myers
- Cassandra LaRose
- Cat Duffy
- Catherine McKee
- Cathren Cohen
- Charlie Blodnieks
- Charly Gilfoil
- Christina Piecora
- Corey Davis
- Dania Douglas
- Daniel Young
- daryln
- David Machledt
- Deanna Hartog
- Elizabeth Edwards
- Elizabeth G. Taylor
- Emma Parker-Newton
- Eskedar Girmash
- Fabiola Carrión
- Georgesula Ziama
- Geron Gadd
- Hannah Eichner
- Hayley Penan
- Héctor Hernández-Delgado
- Ian McDonald
- Jane Perkins
- Jasmine Young
- Jennifer Lav
- Joe McLean
- Kally Xu
- Kasey Nichols
- Kimberly Lewis
- Leonardo Cuello
- lhigashi
- Lisa Munoz
- Liz McCaman Taylor
- Madeline Morcelle
- Mara Youdelman
- Margaret Okakpu
- Maya Levin
- Michelle Lilienfeld
- Michelle Yiu
- Miriam Delaney Heard
- Mizue Suito
- Priscilla Huang
- Rachel Holtzman
- Rolonda Donelson
- Sarah Grusin
- Sarah Somers
- Skyler Rosellini
- Susan Berke Fogel
- T. Nancy Lam
- veng
- Wayne Turner
- Zamir M. Brown
- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- July 23, 2013
Public Health Comments Before the FDA Advisory Committee for Reproductive Healt
Deborah Reid TestimonyRead morePUBLIC HEARING COMMENTS BEFORE THE FDA ADVISORY COMMITTEE FOR REPRODUCTIVE HEALTH DRUGS: New Drug Application (NDA) 22-474, Ulipristal Acetate Tablets (30 mgs) - ?Ella? Emergency Contraceptive For over 30 years, NHeLP, a national public interest law firm, has sought to improve health care and protect the right…
- July 23, 2013
Letter to the Judiciary Committee on H.R. 3, The No Taxpayer Funding for Abort
Read moreThe Honorable Lamar SmithChairman - Committee on the JudiciaryU.S. House of Representatives2138 Rayburn House Office BuildingWashington, DC 20514 RE: February 8, 2011 Hearing on "The No Taxpayer Funding For Abortion Act" (H.R. 3) Dear Chairman Smith and Members of the Judiciary Committee: The National Health Law Program (NHeLP) strongly…
- July 23, 2013
Letter to the Sub-Committee on Health on H.R. 358, The Protect Life Act
Read moreThis letter expresses NHeLP's strong opposition to "The Protect Life Act" as it would impose dangerous and unprecedented restrictions on women's access to abortion services.
- July 23, 2013
How Threats to Medicaid Impact Reproductive Health Disparities
Read moreThe existing entitlement structure of Medicaid is essential to its ability to provide reproductive services to low-income women and women of color. Legislative proposals for ?block grants? or ?funding caps? would dangerously undermine the entitlement structure. Women of reproductive age experience a variety of health disparities, and heavily rely…
- July 23, 2013
NHeLP Breaks Down Five Key Health Reform Standards
Leo Cuello and Susan Berke Fogel Issue BriefRead moreUnderstanding how access to family planning services will be impacted in Exchanges and Medicaid in the coming years requires understanding five key terms in the Affordable Care Act (ACA) which interact with each other in complex ways.
- July 23, 2013
Fact Sheet: Medicaid Family Planning Services Save Money
Read moreThis fact sheet describes the importance and cost-savings of Medicaid coverage of family planning services and supplies.